-
(S)-(-)-二氨基丙烷 二盐酸盐
-
2-Bromo-4-(ethoxycarbonyl)-1,3-thiazole
-
2-(Chloromethyl)-1,3-benzothiazole
-
4-Iodo-2,7-naphthyridin-1(2h)-one
-
2-[2-(4-氟-苯基)-2-氧代-1-苯基-乙基]-4-甲基-3-氧代-戊酸苯酰胺
-
Duvelisib int
-
Methyl 5-broMo-2-hydroxy-4-(trifluoroMethyl)benzoate
-
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
-
氯烯雌醚
-
1-Boc-3-(cyanomethylene)azetidine
-
2-Iodonaphthalene
-
Rucaparib intermediate
-
N-甲氧基-N-甲基-{6-氯-2-叔丁基-7-苯并恶唑}磺酰胺
-
Ethyl 1-(trifluoroMethyl)cyclopropanecarboxylate
-
3-Methoxy-4-(MethylaMino)benzoic acid
-
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
![2-[2-(4-氟-苯基)-2-氧代-1-苯基-乙基]-4-甲基-3-氧代-戊酸苯酰胺](https://stcdn.activebiopharma.com/active/ABP025782.png)
![7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one](https://stcdn.activebiopharma.com/active/ABP025779.png)
![(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan](https://stcdn.activebiopharma.com/active/ABP025771.png)
Copyright © 2015-2025 活性医药. All rights reserved. Support by Moldb.
浙公网安备 33010802003999号